Systemic%20lupus%20erythematosus%20(pediatric) Signs and Symptoms

Signs and Symptoms

Definition

Systemic lupus erythematosus (SLE) is a chronic, multisystem, inflammatory, autoimmune disorder characterized by formation of autoantibodies directed against self-antigens and immune-complex formation
- SLE can be diagnosed with a single organ involvement such as lupus nephritis
Childhood-onset SLE (cSLE) has an estimated worldwide incidence of 0.3-2.2 per 100,000 children-years with prevalence ranging from 3.3-9.7 per 100,000 children and adolescents
- Occurrence is rare before 5 years of age
Females are more often affected than males
Clinical presentation varies in different patients and the disease activity varies over time in a single patient
- Most frequent manifestations in children include fever, rash, weight loss, arthritis and renal involvement
- Compared with adults, cSLE has a higher incidence of fever, lymphadenopathy, ocular symptoms, hematologic abnormalities (eg anemia, leukopenia), neurologic (seizures) and renal involvement (lupus nephritis)
  - cSLE has a greater disease severity and earlier disease damage than in adults with SLE

Signs and Symptoms

Clinical Features of SLE

Cardiac
- Endocarditis
- Myocarditis
- Pericarditis

Constitutional
- Fatigue
- Fever
- Weight loss

Dermatological
- Alopecia
- Malar and/or discoid rash
- Mucous membrane lesion
- Photosensitivity
- Purpura
- Raynaud’s phenomenon
- Urticaria
- Vasculitis

Gastrointestinal
- Abdominal pain
- Nausea, vomiting (N/V)

Hematologic
- Anemia
- Leukopenia
- Lymphopenia
- Thrombocytopenia

Thromboembolic
- Deep vein thrombosis
- Cerebral sinus venous thrombosis
- Pulmonary embolus
- Arterial stroke

Musculoskeletal
- Arthralgia
- Arthritis
- Myositis

Neuropsychiatric
- Headache
- Cognitive impairment
- Mood or anxiety disorders
- Psychosis
- Seizures
- Cerebrovascular disease

Pulmonary
- Pleurisy
- Pulmonary hypertension
- Pneumonitis

Renal
- Casts
- Hematuria
- Nephrotic syndrome
- Proteinuria

Reticuloendothelial
- Hepatomegaly
- Lymphadenopathy
- Splenomegaly

Long COVID: What we have learned so far

Prof. Ghassan Dbaibo, 27 Apr 2023

The WHO defines long COVID as a condition that occurs 3 months from COVID-19 onset, whose symptoms last ≥2 months and cannot be attributed to an alternative diagnosis. In an interview with MIMS Doctor, Professor Ghassan Dbaibo of the Center for Infectious Diseases, American University of Beirut, Beirut, Lebanon, describes the evolving attitudes towards long COVID among healthcare professionals (HCPs), some unexpected predisposing factors, potential biological mechanisms behind prolonged symptom duration and shares data on vaccination’s protective effects against long COVID.

Expert consensus: Patient profile should guide antihistamine choice in primary care setting

10 Dec 2019

Oral H₁-antihistamines are the initial treatment of choice for allergic rhinitis (AR) and chronic urticaria in the primary care setting. However, in a diverse population of patients with AR and urticaria, primary care physicians are faced with the challenge of prescribing the best therapy amid a wide armamentarium of antihistamines available.

Product Highlight - Zinforo

16 Jun 2021

Ceftaroline fosamil 600 mg powder for infusion